Found: 31
Select item for more details and to access through your institution.
Flai (fludarabine, cytarabine, idarubicin) plus low‐dose Gemtuzumab Ozogamicin as induction therapy in CD33‐positive AML: Final results and long term outcome of a phase II multicenter clinical trial.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 5, p. 655, doi. 10.1002/ajh.25057
- By:
- Publication type:
- Article
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. 515, doi. 10.1002/ajh.24000
- By:
- Publication type:
- Article
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 1, p. 22, doi. 10.1002/ajh.22189
- By:
- Publication type:
- Article
Nanoparticles exhibiting self-regulating temperature as innovative agents for Magnetic Fluid Hyperthermia.
- Published in:
- Nanotheranostics, 2021, v. 5, n. 3, p. 333, doi. 10.7150/ntno.55695
- By:
- Publication type:
- Article
Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 9, p. 837, doi. 10.1007/s40261-018-0676-7
- By:
- Publication type:
- Article
IDH2<sup>R172</sup> mutation in angioimmunoblastic T‐cell lymphoma: A retrospective multicenter case series.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 217, doi. 10.1111/ejh.13885
- By:
- Publication type:
- Article
Epstein-Barr virus-related multiple organ failure during treatment with siltuximab in a patient affected by Castleman disease.
- Published in:
- Current Therapeutics, 2022, v. 25, n. 5, p. 43
- By:
- Publication type:
- Article
Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Prognostic Significance of Circulating and Endothelial Progenitor Cell Markers in Type 2 Diabetic Foot.
- Published in:
- International Journal of Vascular Medicine, 2014, p. 1, doi. 10.1155/2014/589412
- By:
- Publication type:
- Article
Combined Use of Growth Factors to Stimulate the Proliferation of Hematopoietic Progenitor Cells after Autologous Bone Marrow Transplantation for Lymphoma Patients.
- Published in:
- Acta Haematologica, 1996, v. 95, n. 3/4, p. 164, doi. 10.1159/000203872
- By:
- Publication type:
- Article
Serum LDH Concentration in Non-Hodgkin's Lymphomas.
- Published in:
- Acta Haematologica, 1984, v. 72, n. 4, p. 231, doi. 10.1159/000206395
- By:
- Publication type:
- Article
What Does Preemptive Antifungal Treatment Really Mean?
- Published in:
- 2010
- By:
- Publication type:
- Letter
Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells.
- Published in:
- International Journal of Oncology, 2016, v. 48, n. 4, p. 1659, doi. 10.3892/ijo.2016.3370
- By:
- Publication type:
- Article
Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell–Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 9, p. e731, doi. 10.1016/j.clml.2021.05.013
- By:
- Publication type:
- Article
Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection.
- Published in:
- 1998
- By:
- Publication type:
- journal article
High-dose therapy followed by autologous bone marrow transplantation (ABMT) in previously untreated non-Hodgkin's lymphoma.
- Published in:
- European Journal of Haematology, 1986, v. 37, n. 4, p. 347, doi. 10.1111/j.1600-0609.1986.tb02325.x
- By:
- Publication type:
- Article
Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Reconstitution
- Published in:
- Hematology Reports, 2022, v. 14, n. 2, p. 135, doi. 10.3390/hematolrep14020020
- By:
- Publication type:
- Article
Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia.
- Published in:
- Hematology Reports, 2017, v. 9, n. 3, p. 87, doi. 10.4081/hr.2017.7028
- By:
- Publication type:
- Article
Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 6, p. 586, doi. 10.1111/ejh.12635
- By:
- Publication type:
- Article
Familial Hemophagocytic Lymphohistiocytosis May Present during Adulthood: Clinical and Genetic Features of a Small Series.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0044649
- By:
- Publication type:
- Article
Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 6, p. 907, doi. 10.1111/bjh.16287
- By:
- Publication type:
- Article
Two novel missense mutations in EPOR gene causes erythrocytosis in two unrelated patients.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 6, p. 908, doi. 10.1111/bjh.14486
- By:
- Publication type:
- Article
Improved efficiency of daratumumab treatment of multiple myeloma adopting the subcutaneous route: A micro‐costing analysis in three Italian hematology centers.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 23, p. 21480, doi. 10.1002/cam4.6699
- By:
- Publication type:
- Article
Doped Ferrite Nanoparticles Exhibiting Self-Regulating Temperature as Magnetic Fluid Hyperthermia Antitumoral Agents, with Diagnostic Capability in Magnetic Resonance Imaging and Magnetic Particle Imaging.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5150, doi. 10.3390/cancers14205150
- By:
- Publication type:
- Article
Lack of efficacy of convalescent plasma in COVID‐19 patients with concomitant hematological malignancies: An Italian retrospective study.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 857, doi. 10.1002/hon.3060
- By:
- Publication type:
- Article
Acquired Isolated Factor VII Deficiency in Plasma Cell Dyscrasias: A Brief Presentation of Two Plasma-Cell-Leukemia-Related Cases and Review of Literature.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 18, p. 5837, doi. 10.3390/jcm12185837
- By:
- Publication type:
- Article
Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinico-pathological study of 69 cases.
- Published in:
- British Journal of Haematology, 1994, v. 86, n. 3, p. 513, doi. 10.1111/j.1365-2141.1994.tb04781.x
- By:
- Publication type:
- Article
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 125, doi. 10.1007/s00277-023-05443-8
- By:
- Publication type:
- Article
Primary cardiac onset of disseminated Burkitt’s lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- Letter
COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.763412
- By:
- Publication type:
- Article
Comparison between the monoclonal antibodies Ki-67 and PC 10 in 125 malignant lymphomas.
- Published in:
- Journal of Pathology, 1993, v. 169, n. 4, p. 397, doi. 10.1002/path.1711690403
- By:
- Publication type:
- Article